Given that one of the exclusion criteria for inclusion of a study participant in the recovered or healthy control group was the lack of any inflammatory illnesses, including non-infectious ones, it is difficult to assess whether the differences in serum AGP concentrations between these groups and the group of patients with severe COVID-19 would have been so pronounced had this exclusion criterion not been applied. This evidence concerns the gene ATP5MK and COVID-19.